Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
See Latest ArticlesEvaluation of Prokinetic Action of Clarithromycin using Orocecal Transit Time in Healthy Human Subjects
The Internet Journal of Gastroenterology, 06/30/09
Shobha JC et al. - The prokinetic action of clarithromycin is substantiated in this study as it significantly reduced OTT as compared to placebo and loperamide. Sulfapyridine lag time in saliva and hence OTT were significantly reduced by clarithromycin indicating its prokinetic effect like erythromycin. However, the clinical utility of this decrease in the lag time has to be evaluated in further studies before any therapeutic indication can be recommended.
Today in Pharmacology/kinetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study
The Lancet - Early Online Publication, 10/19/09
Novel agents for the treatment of adenocarcinoma of the pancreas
Expert Review of Anticancer Therapy, 10/22/09
Methotrexate for maintenance of remission in Crohn's disease
Cochrane Reviews, 10/27/09
Sponsor
Article Search
Sponsor